BSE Live
Oct 21, 14:55Prev. Close
453.05
Open Price
457.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 21, 15:03Prev. Close
454.10
Open Price
454.10
Bid Price (Qty.)
455.40 (4)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 | |
| Total Share Capital | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 | |
| Reserves and Surplus | 576.13 | 495.22 | 464.68 | 436.05 | 374.09 | |
| Total Reserves and Surplus | 576.13 | 495.22 | 464.68 | 436.05 | 374.09 | |
| Total Shareholders Funds | 589.49 | 508.59 | 478.05 | 449.41 | 400.18 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 38.68 | 38.68 | 38.68 | 47.52 | |
| Deferred Tax Liabilities [Net] | 15.58 | 10.92 | 10.65 | 0.00 | 3.63 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | |
| Long Term Provisions | 2.90 | 10.26 | 8.85 | 7.95 | 7.38 | |
| Total Non-Current Liabilities | 18.48 | 59.86 | 58.17 | 46.63 | 58.81 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 68.60 | 42.70 | 48.51 | 49.63 | 68.36 | |
| Other Current Liabilities | 30.55 | 29.06 | 23.27 | 32.23 | 18.78 | |
| Short Term Provisions | 6.08 | 1.05 | 0.89 | 0.75 | 0.68 | |
| Total Current Liabilities | 105.23 | 72.81 | 72.67 | 82.61 | 87.82 | |
| Total Capital And Liabilities | 713.21 | 641.26 | 608.89 | 578.66 | 546.81 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 110.93 | 119.03 | 121.90 | 138.13 | 148.90 | |
| Intangible Assets | 103.21 | 83.73 | 77.77 | 86.54 | 95.30 | |
| Capital Work-In-Progress | 26.39 | 21.08 | 26.10 | 25.23 | 25.11 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 240.53 | 223.85 | 225.77 | 249.90 | 269.31 | |
| Non-Current Investments | 0.16 | 0.16 | 0.14 | 0.14 | 0.14 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.68 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 36.77 | 56.26 | 64.66 | 63.52 | 66.06 | |
| Total Non-Current Assets | 277.46 | 280.26 | 290.57 | 314.25 | 335.51 | |
| CURRENT ASSETS | ||||||
| Current Investments | 84.09 | 19.09 | 20.13 | 0.00 | 0.00 | |
| Inventories | 100.49 | 117.81 | 113.60 | 125.63 | 119.69 | |
| Trade Receivables | 99.26 | 89.54 | 84.92 | 30.41 | 16.44 | |
| Cash And Cash Equivalents | 77.99 | 67.64 | 52.57 | 49.97 | 27.80 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 73.92 | 66.92 | 47.09 | 58.40 | 47.37 | |
| Total Current Assets | 435.75 | 361.00 | 318.32 | 264.41 | 211.30 | |
| Total Assets | 713.21 | 641.26 | 608.89 | 578.66 | 546.81 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 47.92 | 37.46 | 32.91 | 10.83 | 1.29 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.16 | 0.16 | 0.14 | 0.14 | 0.14 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 5.91 | -- | -- | -- | -- |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y